Central nervous system herpesvirus infections

Paediatrics and Child Health (United Kingdom)

Volumn 24, Issue 6, 2014, Pages 248-254

  Britton, Philip ^a   Jones, Cheryl ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Central nervous system; Children; Diagnosis; Encephalitis; Epidemiology; Herpesviruses; Pathogenesis; Treatment

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; CHICKENPOX VACCINE; CIDOFOVIR; CORTICOSTEROID; CYTOMEGALOVIRUS ANTIBODY; FOSCARNET; GANCICLOVIR; PLACEBO; STEROID; VALGANCICLOVIR;

ANTIVIRAL ACTIVITY; BRAIN VASCULITIS; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID ANALYSIS; CHICKENPOX; CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); CORTICOSTEROID THERAPY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DISEASE TRANSMISSION; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FEBRILE CONVULSION; HERPES SIMPLEX; HERPES SIMPLEX ENCEPHALITIS; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HERPES VIRUS; HERPES VIRUS INFECTION; HERPES ZOSTER; HERPES ZOSTER ENCEPHALITIS; HOSPITALIZATION; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; IMMUNOCOMPROMISED PATIENT; INCIDENCE; INFECTION PREVENTION; LABORATORY TEST; LUMBAR PUNCTURE; NEUROLOGIC DISEASE; PARANEOPLASTIC NEUROPATHY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIMARY INFECTION; REHABILITATION CARE; REVIEW; RISK FACTOR; VARICELLA ZOSTER VIRUS; VERTICAL TRANSMISSION; VIRUS ENCEPHALITIS; VIRUS LATENCY; VIRUS STRAIN;

EID: 84901650694     PISSN: 17517222     EISSN: 1878206X     Source Type: Journal    
DOI: 10.1016/j.paed.2013.11.003     Document Type: Review

References (16)

1. Deverell M., Zurynski Y., Elliott E. Australian Paediatric Surveillance Unit annual report, 2011. Commun Dis Intell Q Rep 2012 Sep 30, 36:E263-E267. Chief Investigators of APSU Surveillance Studies.
2. Granerod J., Ambrose H.E., Davies N.W., et al. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 2010, 10:835-844. [Erratum appears in Lancet Infect Dis. 2011 Feb;11(2):79].
3. Hodson E.M., Jones C.A., Strippoli G.F.M., Webster A.C., Craig J.C. Immunoglobulins, vaccines or interferon for preventing cytomegalovirus disease in solid organ transplant recipients. Cochrane Database Syst Rev 2007, Issue 2. Art. No.: CD005129.
4. Hodson E.M., Ladhani M., Webster A.C., Strippoli G.F.M., Craig J.C. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients. Cochrane Database Syst Rev 2013, Issue 2. Art. No.: CD003774.
5. Jones C.A., Isaacs D. Viral infection of the CNS. Forfar and Arneil's textbook of paediatrics 2008, P1292-P1296. Churchill Livingstone Press, London. 7th edn. N. Mcintosh, P. Helms, R. Smyth, R.S. Logan (Eds.).
6. Jones C.A., Walker K., Badawi N. Treatment of symptomatic herpes simplex virus infection in the newborn. Antiviral agents for treatment of herpes simplex virus infection in neonates. Cochrane Database Syst Rev 2009 Jul 8, Issue 3. Art. No.: CD004206.
7. Kimberlin D.W., Baley J. Guidance on management of asymptomatic neonates born to women with active genital herpes lesions. Pediatrics 2013, 131:e635-e646. the AAP Committee on Infectious Diseases and Committee on Fetus and Newborn.
8. Kleines M., Schiefer J., Stienen A., et al. Expanding the spectrum of neurological disease associated with Epstein-Barr virus activity. Eur J Clin Microbiol Infect Dis 2011, 30:1561-1569.
9. Marty F.M., Holmes T.M., Seeley W.W., et al. Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6. Neurology 2007, 69:156-165.
10. McCarthy F., Giles M., Rowlands S., Purcell K., Jones C. Antenatal interventions for preventing the transmission of cytomegalovirus (CMV) from the mother to fetus during pregnancy and adverse outcomes in the congenitally infected infant. Cochrane Database Syst Rev 2011, Issue 3. Art. No.: CD008371.
11. Owers D.S., Webster A.C., Strippoli G.F.M., Kable K., Hodson E.M. Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients. Cochrane Database Syst Rev 2013, Issue 2. Art. No.: CD005133.
12. Schleede L., Bueter W., Baumgartner-Sigl S., et al. Pediatric herpes simplex virus Encephalitis: a retrospective multicenter experience. JChild Neurol 2013, 28:321-331.
13. Steiner I., Kennedy P.G.E., Pachner A.R. The neurotropic herpes viruses: herpes simplex and varicella-zoster. Lancet Neurol 2007, 6:1015-1028.
14. Tunkel A.R., Glaser C.A., Bloch K.C., et al. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2008, 47:303-327.
15. Venkatesan A., Tunkel A., Bloch K., et al. Guidelines and priorities of encephalitis diagnosis: consensus of the international encephalitis consortium. Clin Infect Dis 2013 Oct, 57:1114-1128. on behalf of the International Encephalitis Consortium.
16. Ward K.N., Andrews N.J., Verity C.M., et al. Human herpesviruses-6 and -7 each cause significant neurological morbidity in Britain and Ireland. Arch Dis Child 2005, 90:619-623.